Physician profile
James D Carpenter
NPI 1396820007
$793.39
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $430 · 2020: $17.89 · 2021: $236 · 2023: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $286.71 | 2019-2021 | |
| Biotissue Holdings INC. | $257.33 | 2019 | |
| Rxsight INC | $41.39 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Glaukos Corporation | $38.55 | 2021-2023 | |
| Alcon Vision LLC | $32.27 | 2019 | |
| Ivantis, INC | $30.37 | 2019-2020 | |
| Sight Sciences, INC. | $28.04 | 2019 | |
| Lkc Technologies, INC. | $25.23 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $23.50 | 2019 | |
| Abbvie INC. | $18.09 | 2023 | Durysta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.